Ionis Roche News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data from Spherix Global Insights second annual EU IgAN patient chart audit indicates that even with the EMA approval of FILSPARITM (sparsentan),.

United kingdomIonis rocheEuropean medicines agencySpherix networkSpherix global insightPatient chartIga nephropathyRare glomerular diseasesVera therapeuticsChart dynamixGlobal insightsSpherix global insightsGa nephropathyLomerular diseasesCsl viforSglt2 inhibitors